Form 4: Phillip Frost Acquires 500,000 Shares of OPKO Health (OPK)
SEC Form 4 Filing
Phillip Frost, CEO and Chairman of OPKO Health, purchased 500,000 shares of the company's common stock at a weighted average price of $1.4817 on January 15, 2025.
Summary
- On January 15, 2025, Phillip Frost, the CEO and Chairman of OPKO Health, acquired 500,000 shares of OPKO Health's common stock.
- The shares were purchased at a weighted average price of $1.4817 per share, with individual prices ranging from $1.46 to $1.50.
- Following the transaction, Dr. Frost directly owns 3,568,951 shares.
- Dr. Frost also has indirect ownership through Frost Gamma Investments Trust (213,036,477 shares) and Frost Nevada Investments Trust (30,127,177 shares).
- Dr. Frost disclaims beneficial ownership of the indirectly held shares except to the extent of any pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchase of shares by the CEO can be seen as a vote of confidence, but it's a single transaction and doesn't guarantee future performance.
Positives
- The CEO's purchase of a significant number of shares could be interpreted as a positive signal about the company's prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's important to consider the overall context of the company's performance and industry trends.
Stakeholder Impact
- The stock purchase by the CEO could potentially increase investor confidence.
Key Dates
| Date | Description |
|---|---|
| 01/15/2025 | Date of the transaction: Phillip Frost purchased 500,000 shares of OPKO Health. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.